315 related articles for article (PubMed ID: 30281842)
1. Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).
Hsiao EC; Di Rocco M; Cali A; Zasloff M; Al Mukaddam M; Pignolo RJ; Grunwald Z; Netelenbos C; Keen R; Baujat G; Brown MA; Cho TJ; De Cunto C; Delai P; Haga N; Morhart R; Scott C; Zhang K; Diecidue RJ; Friedman CS; Kaplan FS; Eekhoff EMW
Br J Clin Pharmacol; 2019 Jun; 85(6):1199-1207. PubMed ID: 30281842
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva.
Wentworth KL; Masharani U; Hsiao EC
Br J Clin Pharmacol; 2019 Jun; 85(6):1180-1187. PubMed ID: 30501012
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.
Kaplan FS; Zeitlin L; Dunn SP; Benor S; Hagin D; Al Mukaddam M; Pignolo RJ
Bone; 2018 Apr; 109():281-284. PubMed ID: 29241828
[TBL] [Abstract][Full Text] [Related]
4. Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.
Pignolo RJ; Bedford-Gay C; Cali A; Davis M; Delai PLR; Gonzales K; Hixson C; Kent A; Newport H; Robert M; Scott C; Kaplan FS
Orphanet J Rare Dis; 2022 Apr; 17(1):168. PubMed ID: 35436894
[TBL] [Abstract][Full Text] [Related]
5. Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva.
Pignolo RJ; Al Mukaddam M; Baujat G; Brown MA; De Cunto C; Hsiao EC; Keen R; Le Quan Sang KH; Grogan DR; Marino R; Strahs AR; Kaplan FS
BMC Med Res Methodol; 2023 Nov; 23(1):269. PubMed ID: 37957586
[TBL] [Abstract][Full Text] [Related]
6. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Al Mukaddam M; Pignolo RJ
Bone; 2017 Aug; 101():123-128. PubMed ID: 28465250
[TBL] [Abstract][Full Text] [Related]
7. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
[TBL] [Abstract][Full Text] [Related]
8. Clinical staging of Fibrodysplasia Ossificans Progressiva (FOP).
Pignolo RJ; Kaplan FS
Bone; 2018 Apr; 109():111-114. PubMed ID: 28943457
[TBL] [Abstract][Full Text] [Related]
9. Analog Method for Radiographic Assessment of Heterotopic Bone in Fibrodysplasia Ossificans Progressiva.
Rajapakse CS; Lindborg C; Wang H; Newman BT; Kobe EA; Chang G; Shore EM; Kaplan FS; Pignolo RJ
Acad Radiol; 2017 Mar; 24(3):321-327. PubMed ID: 27989444
[TBL] [Abstract][Full Text] [Related]
10. Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
Pignolo RJ; Baujat G; Brown MA; De Cunto C; Di Rocco M; Hsiao EC; Keen R; Al Mukaddam M; Sang KLQ; Wilson A; White B; Grogan DR; Kaplan FS
Orphanet J Rare Dis; 2019 May; 14(1):98. PubMed ID: 31053156
[TBL] [Abstract][Full Text] [Related]
11. Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).
Pignolo RJ; Hsiao EC; Al Mukaddam M; Baujat G; Berglund SK; Brown MA; Cheung AM; De Cunto C; Delai P; Haga N; Kannu P; Keen R; Le Quan Sang KH; Mancilla EE; Marino R; Strahs A; Kaplan FS
J Bone Miner Res; 2023 Mar; 38(3):381-394. PubMed ID: 36583535
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
Singh S; Kidane J; Wentworth KL; Motamedi D; Morshed S; Schober AE; Hsiao EC
BMC Musculoskelet Disord; 2020 Apr; 21(1):204. PubMed ID: 32245464
[TBL] [Abstract][Full Text] [Related]
13. Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP).
Brennan TA; Lindborg CM; Bergbauer CR; Wang H; Kaplan FS; Pignolo RJ
Bone; 2018 Apr; 109():259-266. PubMed ID: 28851540
[TBL] [Abstract][Full Text] [Related]
14. An unusual case of adult onset progressive heterotopic ossification suggesting a variant form of fibrodysplasia ossificans progressiva.
Jayasundara JA; Punchihewa GL; de Alwis DS
Singapore Med J; 2012 Apr; 53(4):e83-6. PubMed ID: 22511070
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma RANTES in fibrodysplasia ossificans progressiva - A novel therapeutic target?
Grgurević L; Novak R; Trkulja V; Hamzić LF; Hrkač S; Grazio S; Santini M
Med Hypotheses; 2019 Oct; 131():109313. PubMed ID: 31443758
[TBL] [Abstract][Full Text] [Related]
16. Fibroplasia Ossificans Progressiva: A Case Report of a Rare Disease Entity.
Solomon D; Wakjira I; Hailu D; Gorfy Y
Ethiop J Health Sci; 2018 Jul; 28(4):513-516. PubMed ID: 30607064
[TBL] [Abstract][Full Text] [Related]
17. Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases.
Kaplan FS; Andolina JR; Adamson PC; Teachey DT; Finklestein JZ; Ebb DH; Whitehead B; Jacobs B; Siegel DM; Keen R; Hsiao E; Pignolo RJ
Bone; 2018 Apr; 109():276-280. PubMed ID: 28736245
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization.
Pignolo RJ; Hsiao EC; Baujat G; Lapidus D; Sherman A; Kaplan FS
Orphanet J Rare Dis; 2021 Aug; 16(1):350. PubMed ID: 34353327
[TBL] [Abstract][Full Text] [Related]
19. Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry.
Pignolo RJ; Cheung K; Kile S; Fitzpatrick MA; De Cunto C; Al Mukaddam M; Hsiao EC; Baujat G; Delai P; Eekhoff EMW; Di Rocco M; Grunwald Z; Haga N; Keen R; Levi B; Morhart R; Scott C; Sherman A; Zhang K; Kaplan FS
Bone; 2020 May; 134():115274. PubMed ID: 32062004
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).
Kaplan FS; Al Mukaddam M; Pignolo RJ
Bone; 2018 Apr; 109():158-161. PubMed ID: 28600150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
